Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03860519 · ClinicalTrials.gov registry record · NA
The Use of the Propeller Health Platform to Improve Inhaled Corticosteroid (ICS) Use Among Adults With Uncontrolled Persistent Asthma
A NA study, sponsored by Endeavor Health.
- Completed
- Registry status
- NA
- Development phase
- 100
- Enrollment target
NCT03860519: Completed NA study, sponsored by Endeavor Health.
NCT03860519 is a NA study that has completed, run by Endeavor Health. The registered enrollment target is 100 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03860519, a NA study, has completed, sponsored by Endeavor Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 100 participants
- Enrollment target
Study Summary
This is a behavioral randomized controlled trial of adults with uncontrolled persistent asthma that tests if the Propeller Health sensor, mobile application, and dashboard can improve adherence to ICS.
Primary Outcome
Use of the Propeller Health Platform in the treatment group in active mode, compared to the attention control group in silent mode, will demonstrate a 20% change in SABA use and/or minimal clinically important difference (three points) change on the ACT and/or change from ACT score ≤ 19 to ≥20, at 3-months. The 20% change in SABA use = 20 point change (e.g. if a participants uses SABA 40% of days over the 2 week run-in period, and they change SABA use to 20% of days during the final 14 days of t
Interventions
- BEHAVIORAL Electronic Medication Monitors on ICS and SABA - Active Mode
- BEHAVIORAL Electronic Medication Monitors on ICS and SABA - Silent Mode
- BEHAVIORAL Asthma App Tracking of ICS/SABA Usage - Active Mode
- BEHAVIORAL Asthma App Tracking of ICS/SABA Usage - Silent Mode
- BEHAVIORAL NorthShore Connect Real Time ICS and SABA Usage Feedback - Yes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 100 participants |
| Start Date | 2018-03-07 |
| Est. Completion | 2019-08-01 |
| Phase | NA |
What the finished NCT03860519 record still lists
NCT03860519 is an interventional study that assigns participants to a tested intervention. The registered 100 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (93% lower).
The record links to 0 conditions, and to 5 interventions - of which Electronic Medication Monitors on ICS and SABA - Active Mode is the first listed.
NCT03860519 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03860519 about?
NCT03860519 is a clinical study titled "The Use of the Propeller Health Platform to Improve Inhaled Corticosteroid (ICS) Use Among Adults With Uncontrolled Persistent Asthma". This is a behavioral randomized controlled trial of adults with uncontrolled persistent asthma that tests if the Propeller Health sensor, mobile application, and dashboard can improve adherence to ICS.
What is the current status of trial NCT03860519?
This trial is currently completed. It is a NA study. The enrollment target is 100 participants. The study started on 2018-03-07. Estimated completion is 2019-08-01.
What interventions are being tested in trial NCT03860519?
The interventions under investigation include: Electronic Medication Monitors on ICS and SABA - Active Mode (BEHAVIORAL), Electronic Medication Monitors on ICS and SABA - Silent Mode (BEHAVIORAL), Asthma App Tracking of ICS/SABA Usage - Active Mode (BEHAVIORAL), Asthma App Tracking of ICS/SABA Usage - Silent Mode (BEHAVIORAL), NorthShore Connect Real Time ICS and SABA Usage Feedback - Yes (BEHAVIORAL).
Who is sponsoring clinical trial NCT03860519?
This trial is sponsored by Endeavor Health, which has 94 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03860519's enrollment target sits among peer trials
100 840th of 2000 higher than 1,081 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01048281 · 100 participants
Clinical & Pathological Studies of Upper Gastrointestinal Carcinoma
- NCT01161199 · 100 participants
The Use of Leukapheresis to Support HIV Pathogenesis Studies
- NCT01327690 · 100 participants · Early Phase 1
Mental Health in Veterans and Families After Group Therapies
- NCT01730781 · 100 participants
Imaging Cannabinoid Receptors Using Positron Emission Tomography (PET) Scanning
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI